NEW YORK, Nov. 1 - AxCell Biosciences has been awarded a US patent covering nine claims to the company's Cloning of Ligand Targets proteomics technology, AxCell said on Thursday.

“This technology permits the use of ligands … to discover new domains and ultimately new proteins that may be useful as drug targets,” John Rodwell, president and chief technical officer of AxCell, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.